ArticleCureus2025
Orbital Myeloid Sarcoma as the Initial Presentation of Acute Myeloid Leukemia With Maturation in a Pediatric Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute myeloid leukemia (AML) is primarily a disease of adulthood but can also occur in children. Myeloid sarcoma (MS) is an uncommon extramedullary manifestation of AML, and orbital involvement is considered particularly rare, especially in pediatric cases. We report a case of a four-year-old girl from Gaza who developed progressively worsening bilateral orbital swelling and ptosis over four months. Initial assessments, including an eyelid biopsy performed in Gaza, suggested a possible diagnosis of lymphangioma or rhabdomyosarcoma. However, limited access to advanced diagnostic resources and delays in cross-border referral significantly impacted definitive diagnosis. When she was finally referred to Jordan, advanced imaging revealed extensive bilateral retro-orbital masses, severe proptosis, and orbital wall erosion. Histopathological analysis confirmed that MS and bone marrow studies identified AML with maturation (French-American-British classification subtype M2 (FAB-M2)) and the translocation of t (8;21). Despite undergoing three cycles of chemotherapy, she tragically passed away just four months after diagnosis due to complications including encephalopathy and severe infection. This case highlights the aggressive nature of orbital MS in pediatric AML and the critical role of timely access to advanced medical care. It also highlights the devastating impact of healthcare inequities in conflict zones, where diagnostic and treatment delays can significantly worsen outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.